William Starling - Jun 13, 2022 Form 4 Insider Report for ASENSUS SURGICAL, INC. (ASXC)

Role
Director
Signature
/s/ Joshua Weingard, as attorney-in-fact for William N. Starling
Stock symbol
ASXC
Transactions as of
Jun 13, 2022
Transactions value $
-$10,804
Form type
4
Date filed
6/15/2022, 07:36 PM
Previous filing
Jul 2, 2021
Next filing
Jun 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ASXC Common Stock Sale -$10.8K -27K -66.11% $0.40 13.8K Jun 13, 2022 Direct F1
holding ASXC Common Stock 18.1K Jun 13, 2022 See footnote F2
holding ASXC Common Stock 22.8K Jun 13, 2022 See footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ASXC Stock Option Award $0 +55.3K $0.00 55.3K Jun 14, 2022 Common Stock 55.3K $0.38 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.4094 to $0.39, with a weighted average price per share of $0.40. The reporting person undertakes to provide to Asensus Surgical, Inc., any security holder of Asensus Surgical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
F2 Shares of Common Stock held by Synecor, L.L.C. The Reporting Person is the chief executive officer of Synecor, L.L.C. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.
F3 Shares of Common Stock held by W. Starling and D. Starling, Trustees of the Starling Family Trust, UDT August 15, 1990.
F4 Represents an equity award issued under the Registrant's Amended and Restated Incentive Compensation Plan.
F5 The stock options will vest on a quarterly basis over the one year following the date of grant, with the first vesting on the date of grant.